亮氨酸豐富α2-糖蛋白1(LRG1)單克隆抗體
Monoclonal Antibody to Leucine Rich Alpha-2-Glycoprotein 1 (LRG1)
- 編號MAB934Ra22
- 物種Rattus norvegicus (Rat，大鼠)相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)D4
- Ig亞型 IgG1 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原RPB934Ra02-亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度1mg/mL
- 且適物種-
- 應(yīng)用IHC
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 688¥ 1604¥ 2292¥ 5730¥ 22920
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
DAB staining on IHC-P; Sample: Rat Liver Tissue Primary Ab: 30μg/ml Mouse Anti-Rat LRG1 Antibody Control: Used PBS instead of primary antibody Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
Figure. Western Blot; Sample: Recombinant LRG1, Rat.
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對LRG1的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別LRG1。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-30μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB934Ra01 | 亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB934Ra02 | 亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB934Ra01 | 亮氨酸豐富α2-糖蛋白1(LRG1)多克隆抗體 | IHC |
| PAB934Ra02 | 亮氨酸豐富α2-糖蛋白1(LRG1)多克隆抗體 | WB; IHC |
| MAB934Ra22 | 亮氨酸豐富α2-糖蛋白1(LRG1)單克隆抗體 | IHC |
| MAB934Ra21 | 亮氨酸豐富α2-糖蛋白1(LRG1)單克隆抗體 | IHC |
| SEB934Ra | 亮氨酸豐富α2-糖蛋白1(LRG1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB934Ra | 亮氨酸豐富α2-糖蛋白1(LRG1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Clin Exp Nephrol | Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome[PubMed: 26351173] |
| Journal of Proteome Research | Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study[pubmed:28112944] |
| OncoTargets?and Therapy | leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter[Pubmed:29785123] |
| PROTEOMICS?– Clinical Applications | Screening and Identification of Pregnancy Zone Protein (PZP) and Leucine‐Rich Alpha‐2‐Glycoprotein (LRG) as Potential Serum Biomarkers for Early‐onset?…[Pubmed: 30411527] |
| Cancer Management and Research | iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia[Pubmed: 31440093] |
| J Clin Med | A Three-Protein Panel to Support the Diagnosis of Sepsis in Children[Pubmed:35329889] |